10x Genomics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $201.3M | $1.02B | $587.4M |
| FY2022 | $223.2M | $1.03B | $219.7M |
| FY2023 | $224.1M | $965.1M | $359.3M |
| FY2024 | $208.5M | $918.6M | $344.1M |
| FY2025 | $245.0M | $1.04B | $474.0M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $201.3M | $1.02B | $587.4M |
| FY2022 | $223.2M | $1.03B | $219.7M |
| FY2023 | $224.1M | $965.1M | $359.3M |
| FY2024 | $208.5M | $918.6M | $344.1M |
| FY2025 | $245.0M | $1.04B | $474.0M |